ACCELERATE Data Transparency Initiative
The study sponsor (Eli Lilly) and the academic leadership are pleased to announce that the trial database will be made available to independent investigators

• Proposals will be accepted beginning 12 months after the publication of the primary ACCELERATE manuscript
• Review of Proposals and Governance will be coordinated by the academic research organization at the Cleveland Clinic that led the trial (C5Research).
• Further information on submitting research proposals for review will be made available in the future